Topic summary

Comparing prices across jurisdictions without misleading yourself

Access › Pricing compounding data table cost per milligram Solved Wiki

This is a generated summary. It shows the 9 most-liked posts from a topic of 84, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.

t.pereiraTL2 Solution25 May 2026#4

f.villalobos, post #3: Where I part company with the opening post, and it is a narrow parting. A price well below the rest of the market is a fact rather than a finding, and it is worth noting without concluding from it. Go to post

Community wiki post. Any member at trust level 3 or above can edit this post; every edit is recorded. Last edited by revision_history on 8 Jul 2026.

8 Jul 2026 — revision_history: Restructured into sections so the outline is navigable.

Editors: KTurkington, y.mensah, chromatogram, revision_history

My position on comparing prices across jurisdictions is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.

9 likes in reply to #3 2mo

n.kuuselaTL226 May 2026#6

Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented failure of cheaper alternatives.

That much is documented. The rest is how I have interpreted it.

29 likes 2mo

baseline_peakTL2Member1 Jun 2026#26

That is the distinction I keep failing to hold on to. Written down now.

30 likes 2mo

e.ndiayeTL23 Jun 2026#34

Post #32 and I disagree about the size of the effect, not about the direction.

An honest declaration on comparing prices across jurisdictions: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.

32 likes 2mo

baseline_tableTL2Member6 Jun 2026 · edited#46

Adding a data point of agreement rather than a data point.

33 likes 2mo

bench_entryTL3Regular8 Jun 2026#54

e.pires, post #13: Post #12 is the version of this I will quote in future. One addition. I have no financial interest in anything named in this thread and I want to say so before I comment on comparing prices across jurisdictions, because it is the sort of subject where it matters. Go to post

Prices in old topics are historical records and are frequently wrong now. Every post here carries its date for that reason.

Genuinely open to being wrong about this one.

26 likes in reply to #13 2mo

j.mwangiTL4 Moderator11 Jun 2026#64

Building on post #63 rather than restating it.

On comparing prices across jurisdictions, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the interesting bit.

If you can post the two or three numbers you are working from, several people here will check the arithmetic rather than argue about the conclusion.

29 likes 2mo

y.ibarraTL212 Jun 2026 · edited#69

d.eriksen, post #63: Post #59 put the caveat in the right place and I want to underline it. Two claims get bundled together under comparing prices across jurisdictions and they need separating. The descriptive one — this is what was observed — is usually well supported. The causal one — this is why — usually is not. Almost every disagreement in threads like… Go to post

Where the comparing prices across jurisdictions reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.

28 likes in reply to #63 2mo

diluent_watchTL2Member13 Jun 2026#75

PharmNotes_Whitfield, post #7: I had written a reply contradicting post #3 and deleted it. Here is what survived. Second-hand on comparing prices across jurisdictions, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself. Go to post

International pricing: the same compound costs very different amounts in different countries because healthcare systems and regulatory frameworks differ. Generally, US prices are higher than other developed nations.

30 likes in reply to #7 1mo

Read the full topic (84 posts)

Suggested topics

Topic	Participants	Replies	Views	Activity
Manufacturer assistance programmes and their eligibility rules Access › Pricing formulary data table compounding On the subject in the title: Manufacturer assistance programmes and their eligibility rules Working notes rather than a conclusion. I have spent a fortnight trying to pin manufacturer assistance programmes…	+37	42	32k	11d
Cost per delivered dose, which is the number that matters Access › Pricing cost per milligram data table compounding formulary Solved Cost per delivered dose, which is the number that matters — setting out what I have, and where I think it stops being reliable. Documenting an access outcome, dated, because everything in this category…	+54	59	30k	4mo
Pen wastage and its effect on real cost — the long version Access › Pricing formulary data table cost per milligram compounding Posting this under the heading it deserves: Pen wastage and its effect on real cost — the long version Everything below is what sits behind that. A narrow question about Pen wastage, deliberately narrow,…		2	34k	13mo
Coming back to: Cost per delivered dose, which is the number that matters Access › Pricing formulary data table compounding cost per milligram Under review On the subject in the title: Cost per delivered dose, which is the number that matters Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category…	+6	10	2.5k	19mo
[2026 update] Comparing prices across jurisdictions without misleading yourself Access › Pricing formulary compounding data table On the subject in the title: Comparing prices across jurisdictions without misleading yourself Working notes rather than a conclusion. Comparing prices across jurisdictions keeps being re-asked here and I…		2	809	23h

Related topics — sharing the tags compounding, data table, cost per milligram

Topic	Participants	Replies	Views	Activity
Coming back to: Oxidation pathways for methionine and tryptophan Analytics › Impurities & related substances HPLC counter-ion content water content data table Oxidation pathways for methionine and tryptophan Writing it up because I had to work it out twice and would rather nobody else did. Reading back through what has been written here about Oxidation pathways for…	+1	5	36k	15mo
NHS criteria and how they are applied in practice Regional › UK & Ireland NHS cost per milligram personal import MHRA NHS criteria and how they are applied in practice — setting out what I have, and where I think it stops being reliable. I was wrong about NHS criteria in a thread last spring and I would like to correct it…	+37	42	31k	2d
EU-wide position versus national implementation — what changed since Regional › European Union EMA cost per milligram personal import formulary Pinned EU-wide position versus national implementation — what changed since Writing it up because I had to work it out twice and would rather nobody else did. What changes if the standard account of eu-wide position…	+22	26	58k	2mo
Follow-up: UK access routes, dated and sourced Regional › UK & Ireland personal import cost per milligram MHRA Solved On the subject in the title: UK access routes, dated and sourced Working notes rather than a conclusion. Regional question, dated March 2026, because everything in this category expires. The position differs…	+10	14	27k	2d
A rising related-substance total over six months: degradation or method drift? Analytics › Impurities & related substances data table endotoxin testing HPLC Closed Asking directly, because I could not find a straight answer: A rising related-substance total over six months: degradation or method drift? Rising related-substance — I have the observation and I do not trust…	+37	42	37k	23mo